Market Manipulation. Search

AMF France v. EcoR1 Capital LLC and M. Oleg Nodelman (marking the close, 2024)

Judgment entered

Checked against the primary document on October 5, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, in a single reading of the French decision; an independent second reading of 60 of the AMF records agreed on every field for 54 and on the core fields for 59. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (amf-fr-san-2024-12-marking-the-close-2024) by email

In December 2024 the Commission des sanctions fined a San Francisco biotech fund manager EUR 7 million and its founder EUR 3 million for selling Innate Pharma shares in the closing auctions of five sessions in October 2019, which set the price of a Nasdaq offering, and fined the firm for failing to declare crossing the 5 percent threshold.

The record

Structured fields for this action, as recorded in our case library.
Agency AMF (France)
Release number SAN-2024-12
Date filed 2024-12-13
Date resolved 2024-12-13
Court Commission des sanctions (AMF, France)
Status judgment
Asset class equities
Instruments Innate Pharma shares
Venue Euronext Paris
Criminal parallel No
Defendants EcoR1 Capital LLC (entity) ; Oleg Nodelman (individual)
Techniques Marking the close

What was ordered

Civil penalty
—
Disgorgement
—
Prejudgment interest
—
Total relief
—
Alleged gain
—
Penalty as published
€10m

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars. This regulator states penalties in EUR. The figure is recorded as published and is not converted, so it does not appear in the USD totals or medians used elsewhere on this site.

What is alleged to have happened

The Commission des sanctions of the AMF decided the matter on 13 December 2024. The respondents are EcoR1 Capital LLC, a San Francisco investment adviser managing funds that held Innate Pharma shares, and its founder and main shareholder, Oleg Nodelman.

On 7 October 2019 Innate Pharma announced a Nasdaq offering priced on the volume-weighted average of its closing prices on Euronext Paris on 10, 11, 14, 15 and 16 October 2019. The notifications alleged that EcoR1 sold shares at the close on those days, fixing the price at an artificial level, achieving a dominant position and misleading investors, and that it failed to declare threshold crossings in January and October 2019.

The Commission found the manipulation proved on the basis of the price-fixing and closing-time rules, and rejected the separate dominant-position charge. It rejected the argument that only orders entered during the closing phase counted, since transactions executed in the closing fixing are covered too, and it noted that the broker had simply carried out EcoR1's precise instructions. It also found the threshold-crossing breach against EcoR1.

It fined EcoR1 EUR 7,000,000 and Mr Nodelman EUR 3,000,000, EUR 10,000,000 in total, and ordered publication without anonymisation.

The record does not show the price effect in euros, EcoR1's gain or loss, whether the decision was appealed, or any criminal case.

This library tags the matter as marking the close. The tagging is ours, not the regulator's.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the decision.

What technique is this, and how does it work?

This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

Timeline

  1. 2024-12-13 Commission des sanctions decision

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

The linked release is published by the issuing regulator under its own terms. Our summary and narrative above are our own writing.

Other actions in the library sharing at least one technique tag with this one.

Action Agency Filed Technique Penalty Status
ASIC v. Delta Power & Energy (Vales Point) Pty Ltd (price manipulation, 2025) ASIC 2025-06-30 Price Manipulation , Marking The Close — filed
ASIC v. COFCO International Australia Pty Ltd (marking the close, 2024) ASIC 2024-07-24 Marking The Close , Price Manipulation — filed
ASIC v. Interactive Brokers (marking the close, 2023) ASIC 2023-09-20 Marking The Close — settled
SEBI v. Aventis Biofeeds Private Limited and others (closing-session price ramp, Ruchi Soya, 2022) SEBI (India) 2022-04-29 Marking The Close , Settlement Price Manipulation — judgment
SEC v. Ahmad Haris Tajyar and Eric Leo Marsoubian (marking the close, 2021) SEC 2021-08-13 Marking The Close , Matched Orders +1 $220k settled
SEC v. Andrew J. Kandalepas (marking the close, 2019) SEC 2019-06-21 Marking The Close — judgment

Record added October 5, 2026. submit a correction.